[1] Fonseca, C.P., Montezinho, L.P. and Castro, M.M.C.A. (2012) Li+ in Bipolar Disorder—Possible Mechanisms of Its Pharmacological Mode of Action. In: Barnhill, J., Ed., Bipolar Disorder—A Portrait of a Complex Mood Disorder.
[2] Bezchlibnyk, Y. and Young, L.T. (2002) The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression. Canadian Journal of Psychiatry, 47, 135-148.
[3] Belmaker, R.H. (2004) Bipolar Disorder. New England Journal of Medicine, 351, 476-486.
http://dx.doi.org/10.1056/NEJMra035354
[4] Martinez-Aran, A., et al. (2004) Cognitive Function across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder. American Journal of Psychiatry, 161, 262-270. http://dx.doi.org/10.1176/appi.ajp.161.2.262
[5] Goldberg, J.F. and Roy, K.N. (2009) Chengappa, Identifying and Treating Cognitive Impairment in Bipolar Disorder. Bipolar Disorders, 11, 123-137.
http://dx.doi.org/10.1111/j.1399-5618.2009.00716.x
[6] Melchior, M., et al. (2007) Work Stress Precipitates Depression and Anxiety in Young, Working Women and Men. Psychological Medicine, 37, 1119-1129.
http://dx.doi.org/10.1017/S0033291707000414
[7] Hammen, C., Brennan, P.A. and Shih, J.H. (2004) Family Discord and Stress Predictors of Depression and Other Disorders in Adolescent Children of Depressed and Nondepressed Women. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 994-1002.
http://dx.doi.org/10.1097/01.chi.0000127588.57468.f6
[8] American Psychiatric Association (2000) Mood Disorders. In: Diagnostic and Statistical Manual of Mental Disorders: 4th Edition: DSM-IV-TR®, American Psychiatric Association, Arlington.
[9] Duman, R.S. (2002) Synaptic Plasticity and Mood Disorders. Molecular Psychiatry, 7, S29-S34.
http://dx.doi.org/10.1038/sj.mp.4001016
[10] Cade, J.F. (2000) Lithium Salts in the Treatment of Psychotic Excitement 1949. Bulletin of the World Health Organization, 78, 518-520.
[11] Baldessarini, R.J., Tondo, L. and Hennen, J. (1999) Effects of Lithium Treatment and Its Discontinuation on Suicidal Behavior in Bipolar Manic-Depressive Disorders. The Journal of Clinical Psychiatry, 60, 77-84; discussion 111-116.
[12] Malhi, G.S., et al. (2013) Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs, 27, 135-153.
http://dx.doi.org/10.1007/s40263-013-0039-0
[13] Grandjean, E.M. and Aubry, J.-M. (2009) Lithium: Updated Human Knowledge Using an Evidence-Based Approach: Part II: Clinical Pharmacology and Therapeutic Monitoring. CNS Drugs, 23, 331-349.
http://dx.doi.org/10.2165/00023210-200923040-00005
[14] Ward, M.E., Musa, M.N. and Bailey, L. (1994) Clinical Pharmacokinetics of Lithium. The Journal of Clinical Pharmacology, 34, 280-285. http://dx.doi.org/10.1002/j.1552-4604.1994.tb01994.x
[15] Bauer, L.A. (2008) Lithium. In: Applied Clinical Pharmacokinetics, The McGraw-Hill Companies, New York.
[16] Sproule, B.A., Hardy, B.G. and Shulman, K.I. (2000) Differential Pharmacokinetics of Lithium in Elderly Patients. Drugs & Aging, 16, 165-177. http://dx.doi.org/10.2165/00002512-200016030-00002
[17] Thornhill, D.P. (1978) Pharmacokinetics of Ordinary and Sustained-Release Lithium Carbonate in Manic Patients after Acute Dosage. European Journal of Clinical Pharmacology, 14, 267-271. http://dx.doi.org/10.1007/BF00560460
[18] Gai, M.A.N., et al. (2000) Effect of Three Different Diets on the Bioavailability of a Sustained Release Lithium Carbonate Matrix Tablet. International Journal of Clinical Pharmacology and Therapeutics, 38, 320-326.
http://dx.doi.org/10.5414/CPP38320
[19] Prien, R.F. and Caffey, E.M. (1976) Relationship between Dosage and Response to Lithium Prophylaxis in Recurrent Depression. The American Journal of Psychiatry, 133, 567-570.
[20] Stokes, P.E., Kocsis, J.H. and Arcuni, O.J. (1976) Relationship of Lithium Chloride Dose to Treatment Response in Acute Mania. Archives of General Psychiatry, 33, 1080.
http://dx.doi.org/10.1001/archpsyc.1976.01770090070006
[21] Speirs, J. and Hirsch, S.R. (1978) Severe Lithium Toxicity with “Normal” Serum Concentrations. British Medical Journal, 1, 815. http://dx.doi.org/10.1136/bmj.1.6116.815
[22] Mitchell, P.B. (2001) Therapeutic Drug Monitoring of Psychotropic Medications. British Journal of Clinical Pharmacology, 52, 45-54. http://dx.doi.org/10.1111/j.1365-2125.2001.00174.x
[23] Gadallah, M.F., Feinstein, E.I. and Massry, S.G. (1988) Lithium Intoxication: Clinical Course and Therapeutic Considerations. Mineral and Electrolyte Metabolism, 14, 146-149.
[24] Mosteller, R.D. (1987) Simplified Calculation of Body-Surface Area. The New England Journal of Medicine, 317, 1098. http://dx.doi.org/10.1056/NEJM198710223171717
[25] Tietz, N.W. (1995) Clinical Guide to Laboratory Tests. WB Saunders Co., Philadelphia.
[26] Amdisen, A. (1975) Monitoring of Lithium Treatment through Determination of Lithium Concentration. Danish Medical Bulletin, 22, 277-291.
[27] Lehmann, K. and Merten, K. (1974) Die Elimination von Lithiumin Abhangigkeit vom Lebensalter bei Gesunden und Niereninsuffizienten. International Journal of Clinical Pharmacy, 10, 292-298.
[28] Reiss, R.A., et al. (1994) Lithium Pharmacokinetics in the Obese. Clinical Pharmacology & Therapeutics, 55, 392-398.
http://dx.doi.org/10.1038/clpt.1994.47
[29] Amdisen, A. (1977) Serum Level Monitoring and Clinical Pharmacokinetics of Lithium. Clinical Pharmacokinetics, 2, 73-92. http://dx.doi.org/10.2165/00003088-197702020-00001
[30] Platman, S.R. and Fieve, R.R. (1968) Biochemical Aspects of Lithium in Affective Disorders. Archives of General Psychiatry, 19, 659-663. http://dx.doi.org/10.1001/archpsyc.1968.01740120019003